GOODMAN JESSE
SEC CIK 1756929 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | Dir | 33.6K | — | $29.1K | 6 | 2022-06-14 | 2026-06-09 |
Most active insiders at NTLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| 2 | Cohen Fred E | Dir | $1.40M | — |
| 3 | Dulac Edward J III | EVP, CFO | — | $234.2K |
| 4 | BASTA JAMES | EVP, GC | — | $112.4K |
| 5 | Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| 6 | Dube Michael P | VP, CAO | — | $104.4K |
| 7 | Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| 8 | Schultes Birgit C | EVP, CSO | — | $78.9K |
| 9 | Bhanji Muna | Dir | — | — |
| 10 | Keresty Georgia | Dir | — | — |
| 11 | GOODMAN JESSE | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-10 19:06 | 2026-06-09 | NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Dir | A - Grant | $0.00 | +9,200 | 33.6K | +38% | $0 |
| MT | 2025-07-02 | 2025-06-30+ | NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Dir | S - Sale | $9.40 | -3,094 | 25.9K | -11% | -$29.1K |
| D | 2025-06-13 | 2025-06-11 | NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Dir | A - Grant | $0.00 | +8,000 | 27.5K | +41% | $0 |
| D | 2024-06-14 | 2024-06-12 | NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Dir | A - Grant | $0.00 | +7,737 | 19.5K | +66% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Dir | A - Grant | $0.00 | +4,425 | 11.7K | +61% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Intellia Therapeutics, Inc. | GOODMAN JESSE | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
Purchase Sale Sale after option exercise All abbreviations